Evaluating anti-viral drug selection and treatment duration in HBeAg-negative chronic hepatitis B: a cost-effectiveness analysis.

Source:http://linkedlifedata.com/resource/pubmed/id/18373637

Download in:

View as

General Info

PMID
18373637